Aβ*56 is a stable oligomer that correlates with age-related memory loss in Tg2576 mice
暂无分享,去创建一个
K. Zahs | K. Ashe | P. Liu | M. Grant | Samantha L. Shapiro | Lisa J. Kemper | Ian P. Lapcinski | Samantha L. Shapiro | Karen H. Ashe
[1] V. Daggett,et al. SOBA: Development and testing of a soluble oligomer binding assay for detection of amyloidogenic toxic oligomers , 2022, Proceedings of the National Academy of Sciences of the United States of America.
[2] E. Siemers,et al. ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s Disease , 2022, Frontiers in Neuroscience.
[3] V. Daggett,et al. Amyloid- β Oligomers: Multiple Moving Targets , 2022 .
[4] J. Collinge,et al. Highly infectious prions are not directly neurotoxic , 2020, Proceedings of the National Academy of Sciences.
[5] Y. Suh,et al. Longitudinal profiling of oligomeric Aβ in human nasal discharge reflecting cognitive decline in probable Alzheimer’s disease , 2020, Scientific Reports.
[6] K. Ashe. The biogenesis and biology of amyloid β oligomers in the brain , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[7] R. Petersen,et al. A soluble truncated tau species related to cognitive dysfunction is elevated in the brain of cognitively impaired human individuals , 2020, Scientific Reports.
[8] K. Zahs,et al. A Cautionary Tale: Endogenous Biotinylated Proteins and Exogenously-Introduced Protein A Cause Antibody-Independent Artefacts in Western Blot Studies of Brain-Derived Proteins , 2019, Biological Procedures Online.
[9] K. Zahs,et al. Human cerebrospinal fluid 6E10-immunoreactive protein species contain amyloid precursor protein fragments , 2019, PloS one.
[10] Y. Suh,et al. Differential spatial expression of peripheral olfactory neuron-derived BACE1 induces olfactory impairment by region-specific accumulation of β-amyloid oligomer , 2017, Cell Death & Disease.
[11] Peng Liu,et al. Quantitative Comparison of Dense-Core Amyloid Plaque Accumulation in Amyloid-β Protein Precursor Transgenic Mice. , 2017, Journal of Alzheimer's disease : JAD.
[12] M. Gairí,et al. Aβ42 assembles into specific β-barrel pore-forming oligomers in membrane-mimicking environments , 2016, Proceedings of the National Academy of Sciences.
[13] K. Rhodes,et al. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease , 2016, Nature.
[14] K. Zahs,et al. Quaternary Structure Defines a Large Class of Amyloid-β Oligomers Neutralized by Sequestration. , 2015, Cell reports.
[15] K. Zahs,et al. Characterization of a Novel Mouse Model of Alzheimer’s Disease—Amyloid Pathology and Unique β-Amyloid Oligomer Profile , 2015, PloS one.
[16] Urmi Sengupta,et al. Tau Immunotherapy Modulates Both Pathological Tau and Upstream Amyloid Pathology in an Alzheimer's Disease Mouse Model , 2015, The Journal of Neuroscience.
[17] Shaomin Li,et al. Secreted Amyloid β-Proteins in a Cell Culture Model Include N-Terminally Extended Peptides That Impair Synaptic Plasticity , 2014, Biochemistry.
[18] David A Bennett,et al. Brain amyloid-β oligomers in ageing and Alzheimer's disease. , 2013, Brain : a journal of neurology.
[19] H. Vinters,et al. AD synapses contain abundant Aβ monomer and multiple soluble oligomers, including a 56-kDa assembly , 2012, Neurobiology of Aging.
[20] N. Toni,et al. An Effector-Reduced Anti-β-Amyloid (Aβ) Antibody with Unique Aβ Binding Properties Promotes Neuroprotection and Glial Engulfment of Aβ , 2012, The Journal of Neuroscience.
[21] C. Cotman,et al. Aβ aggregation profiles and shifts in APP processing favor amyloidogenesis in canines , 2012, Neurobiology of Aging.
[22] R. Kayed,et al. Amyloid-β Annular Protofibrils Evade Fibrillar Fate in Alzheimer Disease Brain*♦ , 2011, The Journal of Biological Chemistry.
[23] K. Zahs,et al. Grape seed polyphenolic extract specifically decreases aβ*56 in the brains of Tg2576 mice. , 2011, Journal of Alzheimer's disease : JAD.
[24] Rie Teraoka,et al. A Mouse Model of Amyloid β Oligomers: Their Contribution to Synaptic Alteration, Abnormal Tau Phosphorylation, Glial Activation, and Neuronal Loss In Vivo , 2010, The Journal of Neuroscience.
[25] L. Mucke,et al. Neprilysin Overexpression Inhibits Plaque Formation But Fails to Reduce Pathogenic Aβ Oligomers and Associated Cognitive Deficits in Human Amyloid Precursor Protein Transgenic Mice , 2009, The Journal of Neuroscience.
[26] C. Glabe,et al. Structural Classification of Toxic Amyloid Oligomers* , 2008, Journal of Biological Chemistry.
[27] Shaomin Li,et al. Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory , 2008, Nature Medicine.
[28] D. Teplow,et al. Grape-Derived Polyphenolics Prevent Aβ Oligomerization and Attenuate Cognitive Deterioration in a Mouse Model of Alzheimer's Disease , 2008, The Journal of Neuroscience.
[29] Dag Sehlin,et al. Sensitive ELISA detection of amyloid‐β protofibrils in biological samples , 2007 .
[30] Elizabeth Head,et al. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers , 2007, Molecular Neurodegeneration.
[31] L. Mucke,et al. Accelerating Amyloid-β Fibrillization Reduces Oligomer Levels and Functional Deficits in Alzheimer Disease Mouse Models* , 2007, Journal of Biological Chemistry.
[32] J. D. McGaugh,et al. Learning Decreases Aβ*56 and Tau Pathology and Ameliorates Behavioral Decline in 3xTg-AD Mice , 2007, The Journal of Neuroscience.
[33] M. Gallagher,et al. A specific amyloid-β protein assembly in the brain impairs memory , 2006, Nature.
[34] Charles Weissmann,et al. The state of the prion , 2004, Nature Reviews Microbiology.
[35] L. Mucke,et al. Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation , 2004, Nature Medicine.
[36] Kazuki Sato,et al. Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[37] Carl W. Cotman,et al. Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.
[38] W. K. Cullen,et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.
[39] George A. Carlson,et al. The Relationship between Aβ and Memory in the Tg2576 Mouse Model of Alzheimer's Disease , 2002, The Journal of Neuroscience.
[40] Kang Hu,et al. High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.
[41] S. Younkin,et al. Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.
[42] M. Emmerling,et al. Morphology and Toxicity of Aβ-(1-42) Dimer Derived from Neuritic and Vascular Amyloid Deposits of Alzheimer's Disease* , 1996, The Journal of Biological Chemistry.
[43] T. Holzman,et al. Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths. , 1994, Biophysical journal.
[44] C. Weissmann. The prion's progress , 1991, Nature.
[45] C. Weissmann. Spongiform encephalopathies. The prion's progress. , 1991, Nature.
[46] R. Morris. Developments of a water-maze procedure for studying spatial learning in the rat , 1984, Journal of Neuroscience Methods.